Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Lowe Syndrome, also known as oculocerebrorenal syndrome of Lowe (OCRL), is a rare genetic disorder characterized by the triad of congenital cataracts, mental retardation, and renal tubular dysfunction. The disorder is caused by mutations in the OCRL1 gene, which encodes…

Pseudophakia, is a Latin word, made up of two parts pseudo (fake or artificial) and phakia(lens). It is an incredible visual rehabilitation technique, where an artificial İntraocular lens is introduced into the affected eye after the extraction of a cloudy…

HOYA Surgical Optics (“HSO”), the intraocular lens and related products division of HOYA Group, today announced that it has completed the acquisition of medical device companies Mid Labs and Fritz Ruck. Mid Labs is a California-based company focused on the…

Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…

The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market…

Cataract surgery is the most frequently performed operative procedure worldwide, typically concludes with the implantation of an artificial intraocular lens (IOL) to correct aphakia (absence of the crystalline lens). The surgery—which involves removing the eye’s clouded lens and replacing it…

Cataract surgery has revolutionized the way we restore vision, but what happens when clarity begins to fade post-surgery? This is where YAG laser capsulotomy steps in, offering a solution that restores vision and rejuvenates the eyes. In this article, we’ll…

Lupin Limited, a global pharmaceutical company, has officially received approval from the US FDA for its Abbreviated New Drug Application for Bromfenac Ophthalmic Solution, 0.09%. This approval allows Lupin to introduce a generic counterpart to Bausch & Lomb Inc.’s Bromday…

The Medicines and Healthcare products Regulatory Agency (MHRA) has recently issued a National Patient Safety Alert due to reports of increased intraocular pressure in patients recently implanted with EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses (IOLs), which…

What Is Fuchs’ Dystrophy? Fuchs’ dystrophy is a progressive, inherited disease that affects the cornea, the clear outer layer of the eye. This condition is named after Ernst Fuchs, the Austrian ophthalmologist who first described it in 1910. Fuchs’ dystrophy…